Overview (20 Jul 2021)
ALEMBIC LTD.
ALEMBICLTD
INE426A01027

Pharmaceuticals
Result was last declared on 03 Nov 2020
-5.3

Prev. Close
Previous Close
135.65
Current Close
130.35
Current High
137.25
Current Low
128.2
52 Week High
143.3
52 Week Low
74
Resistance 1
135.66
Resistance 2
140.98
Support 1
126.61
Support 2
117.56
Std Deviation
2.04%
DMA 200
108.95
DMA 50
129.26
DMA 20
128.79
Fundamentals and Ratios
Standalone
Trailing EPS
0.52
Forwad EPS
0.59
Trailing P/E
250.67
Forward P/E
222.19
PEG Ratio
17.3308
Mkt. Cap (Cr)
Market Cap (Cr)
3347.15
Total Debt(Cr)
Tot. Debt(Cr)
8.88
Reserve (Cr)
1366.69
Book Value
54.69
P/BV Ratio
2.38
ROCE(%)
1.00
ROE
1.00
Consolidated
Trailing EPS
13.35
Forwad EPS
13.2
Trailing P/E
10.07
Forward P/E
10.19
PEG Ratio
-9.07
Mkt. Cap (Cr)
Market Cap (Cr)
3453.72
Total Debt(Cr)
Tot. Debt(Cr)
8.88
Reserve (Cr)
1366.69
Book Value
55.20
P/BV Ratio
2.44
ROCE(%)
1.00
ROE
1.00

 

Financial Result
Standalone
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue28.5414.1816.4913.111.3672.3
Other Income1.722.742.692.8157.299.97
Total Income30.2616.9219.1815.9168.6582.27
Interest0.070.080.060.060.080.27
Expenditure-25.73-11.50-15.13-13.40-13.03-65.75
PBDT0.000.000.000.000.000.00
Depreciation-1.00-1.02-0.97-0.93-0.90-3.91
PBT4.535.424.052.5155.6216.52
Tax-0.90-0.93-0.89-0.43-0.16-3.16
Equity0.000.000.000.000.000.00
OPM15.8738.2224.5619.16489.6120.00
Net Profit3.634.493.162.0855.4613.36
NPM12.7131.6619.1615.88488.216
EPS0.140.180.120.082.160.52
Consolidated
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue28.8914.4816.7613.3911.4873.52
Other Income1.773.022.682.8257.2710.28
Total Income30.6617.5019.4416.2168.7583.79
Interest0.090.100.080.090.090.36
Expenditure-26.07-11.70-15.33-13.67-13.13-66.75
PBDT0.000.000.000.000.000.00
Depreciation-1.03-1.02-0.97-0.93-0.90-3.94
PBT4.595.804.112.5455.6217.04
Tax-0.95-0.93-0.89-0.43-0.16-3.20
Equity0.000.000.000.000.000.00
OPM14.9833.1421.1415.6780.9020.34
Net Profit71.9485.5996.7988.52115.42342.85
NPM234.67489.09497.89546.08167.88409.17
EPS2.83.333.773.454.513.35
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2020Final Dividend0.60Final Dividend - Rs. - 0.600029 Jul 2020
2019Final Dividend0.20Final Dividend - Rs. - 0.200018 Sep 2019
2018Final Dividend0.20Dividend - Rs. - 0.200027 Jul 2018
2017Final Dividend0.20Dividend - Rs. - 0.200019 Jul 2017
2016Final Dividend0.15Dividend - Rs. - 0.150001 Aug 2016
2015Final Dividend0.15Dividend - Rs. - 0.150003 Aug 2015
2014Final Dividend0.15Dividend - Rs. - 0.150004 Aug 2014
2013Final Dividend0.20Dividend - Rs. - 0.200026 Aug 2013
2010Final Dividend0.50Dividend - Rs. - 0.500021 Jul 2010
2009Final Dividend0.40Dividend - Rs. - 0.400017 Jul 2009
2008Final Dividend1.50Dividend - Rs. - 1.500017 Jul 2008
Bonus
YearRatioRemarkEx Date
20131:1Bonus issue 1:127 Sep 2013
Split

Mutual Fund Holddings
Fund NameQuantity (in thousand)
SBI Small Cap Fund
10,000.00
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
730.65
26.42
ABBOTINDIA
17484.45
53.79
AJANTPHARM
2155.25
27.78
ALBERTDAVD
540.8
13.94
ALEMBICLTD
134.5
258.65
ALKEM
3351.15
23.78
AMBALALSA
31.75
-26.02
ANUHPHR
139.2
24.51
APLLTD
968.6
15.97
AREYDRG
37.9
13.58
ARMOURPO
172.05
19.6
ASTRAZEN
3517.35
94.25
AUROLAB
179.1
15.55
AUROPHARMA
975.55
18.36
BAJAJHCARE
918.15
15.24
12345678910
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020